Skip to main content

The dabl Solution

For Contract Research Organisations (CROs)

Portfolio Level Delivery Risk

In clinical trials, blood pressure data is often fragmented. Multiple sites, regions, sponsors, devices and measurement methods each introduce variation, creating deceptive complexity and compounding headaches for data teams.

Protocol deviations, incomplete data and lengthy database locks are a common reality when BP data is not centralised. For CROs managing multiple trials across different sponsors, what begins as a site-level risk quickly becomes a portfolio-level delivery risk.

The dabl Answer

After years of industry experience in clinical and cardiovascular industries, dabl heard and answered the call for standardised, structured blood pressure data capture.  As blood pressure specialists – this is what we do.

Standardised Blood Pressure Across Studies & Sponsors

Centralised capture from validated Home, Office, and ABPM devices ensures consistency across every trial. Where BP is a key endpoint, dabl brings the gold standard for blood pressure measurement to decentralised trials.

Configuration follows your protocol. Measurement windows, role-based permissions, blinding controls, and EDC export formats are all tailored to your exact study requirements.

Fewer Queries, Faster Database Locks

Real-time automated validation replaces time-consuming manual reviews. BP queries are reduced at both site and data management level — and because errors are detected at the point of capture, complete, valid data reaches your EDC from the start. The result: faster database locks where blood pressure is material.

Confidence in Data Accuracy

All data is validated at capture to ensure accuracy and compliance with protocol and local regulations. By eliminating manual data touchpoints, dabl removes the opportunity for human error — data moves directly from digital device to database.

Audit trails record the who, what, when, and why of every action or change. Combined with role-based permissions and encrypted access controls, the dabl system ensures the integrity of both actions and unblinded data.

Without dabl

1

Step 01 Device selection

Sites choose their own devices. No standardisation across regions or sponsors.
Inconsistent measurements
2

Step 02 Data capture

Paper or local systems. Manual entry introduces transcription errors and gaps.
Error-prone
3

Step 03 Validation

Batch review at data management stage. Errors only discovered after accumulation.
Late detection
4

Step 04 Query management

High query volumes at lock. Site staff burden increases. Timelines slip.
Portfolio delivery risk
5

Step 05 Database lock

Delayed by outstanding queries, reconciliation, and audit trail gaps.
Delayed lock

With dabl

1

Step 01 Centralised Device Provision

Validated, regionally approved devices supplied and calibrated by dabl.
Standardised from the start
2

Step 02 Automated Data capture

Data captured directly from device to database — no manual transcription.
Zero manual touchpoints
Error-prone
3

Step 03 Real-Time Validation

Every reading validated at point of capture against protocol rules.
Errors caught immediately
4

Step 04 Minimal Queries

Complete, valid data ready to enter the EDC dramatically reducing query burden.
Reduced site burden
5

Step 05 Fast, clean lock

Automated audit trails and complete datasets mean faster, cleaner database locks. On schedule

Advantages of Using dabl in Clinical Trials

Real-time, automatic validation of blood pressure data

Improved patient retention

Vast experience in global, multi-site trials

Our system is configured to your study protocol

End-to-end service enables faster trial set-up & close-out

Reduces operational costs without compromising data quality

100% evaluable data

Analyses and presents data in line with International Guidelines

Trusted advice and expertise on study protocol

24/7 support